Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume -, Issue -, Pages -Publisher
WILEY
DOI: 10.1002/mnfr.202000489
Keywords
bioavailability; coffee; dietary pattern; human intervention study; pyridine
Categories
Funding
- Soremartec Italia S.r.l. (Ferrero Group, Alba, Italy)
Ask authors/readers for more resources
Scope The present study assesses the absorption, pharmacokinetics, and urinary excretion of coffee pyridines and their metabolites after daily regular exposure to specific dosages of coffee or cocoa-based products containing coffee (CBPCC), considering different patterns of consumption. Methods and results In a three-arm, crossover, randomized trial, 21 volunteers are requested to randomly consume for 1 month: one cup of espresso coffee per day, three cups of espresso coffee per day, or one cup of espresso coffee plus two CBPCC twice per day. The last day of the one-month treatment, blood and urine samples are collected for 24 h. Trigonelline,N-methylpyridinium,N-methylnicotinamide, andN-methyl-4-pyridone-5-carboxamide are quantified. Trigonelline andN-methylpyridinium absorption curves and 24-h urinary excretion reflect the daily consumption of different servings of coffee or CBPCC, showing also significant differences in main pharmacokinetic parameters. Moreover, inter-subject variability due to sex and smoking is assessed, showing sex-related differences in the metabolism of trigonelline and smoking-related ones forN-methylpyridinium. Conclusion The daily exposure to coffee pyridines after consumption of different coffee dosages in a real-life setting is established. This data will be useful for future studies aiming at evaluating the bioactivity of coffee-derived circulating metabolites in cell experiments, mimicking more realistic experimental conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available